Literature DB >> 16253018

High-grade pancreatic intraepithelial neoplasia in a patient with familial adenomatous polyposis.

Chakshu Gupta1, Paul F Mazzara.   

Abstract

Familial adenomatous polyposis (FAP) is caused by mutation of the adenomatous polyposis coli (APC) gene and is characterized by multiple colorectal adenomas and tumors of other organs and sites. A 58-year-old woman with FAP syndrome and previous total colectomy presented for routine follow-up examination. Abdominal ultrasound and subsequent endoscopic evaluation revealed ampullary and duodenal polyps, as well as inhomogeneity of the pancreatic head. A pancreaticoduodenectomy confirmed multiple duodenal adenomas. In addition, high-grade pancreatic intraepithelial neoplasia (PanIN-3) was found in the smaller pancreatic ducts. Pancreatic precancerous lesions have only rarely been described in FAP, including 2 pancreatic duct adenomas and 2 intraductal papillary mucinous neoplasms. A review of the world English literature revealed no reports of PanIN-3 in association with FAP. Further studies are required to determine if patients with FAP are at increased risk for pancreatic premalignant lesions.

Entities:  

Mesh:

Year:  2005        PMID: 16253018     DOI: 10.5858/2005-129-1398-HPINIA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

Review 1.  Extra-intestinal manifestations of familial adenomatous polyposis.

Authors:  Emma J Groen; Annemieke Roos; Friso L Muntinghe; Roelien H Enting; Jakob de Vries; Jan H Kleibeuker; Max J H Witjes; Thera P Links; André P van Beek
Journal:  Ann Surg Oncol       Date:  2008-07-09       Impact factor: 5.344

Review 2.  Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy.

Authors:  Rille Pihlak; Jamie M J Weaver; Juan W Valle; Mairéad G McNamara
Journal:  Cancers (Basel)       Date:  2018-01-12       Impact factor: 6.639

Review 3.  Germline mutations in pancreatic cancer and potential new therapeutic options.

Authors:  Rille Pihlak; Juan W Valle; Mairéad G McNamara
Journal:  Oncotarget       Date:  2017-04-20

Review 4.  Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients.

Authors:  Shannon R Nelson; Naomi Walsh
Journal:  Cancers (Basel)       Date:  2020-05-14       Impact factor: 6.639

5.  Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.

Authors:  N Moniaux; S Chakraborty; M Yalniz; J Gonzalez; V K Shostrom; J Standop; S M Lele; M Ouellette; P M Pour; A R Sasson; R E Brand; M A Hollingsworth; M Jain; S K Batra
Journal:  Br J Cancer       Date:  2008-04-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.